Elcoxial Tablet 30 mg (Etoricoxib)

Adult dose

Before administering this medicine, consider the potential risks and benefits of this medicine and alternative treatments. As cardiovascular risk increases with higher doses and longer exposure to this medicine, use it for the shortest possible duration. Adverse reactions such as hypertension, congestive heart failure, and edema may occur during treatment with this medicine. Therefore, at least monthly, regularly reassess whether treatment should be continued based on symptom relief and the patient's response to treatment. This medicine may be taken with or without food. Adults: The recommended dose is 30 mg once daily, and the dose should not exceed 30mg daily. If there is no therapeutic benefit at the recommended dose, discontinue this medicine and consider an appropriate alternative treatment. Patients with hepatic impairment: No dose adjustment is required in patients with mild to moderate hepatic impairment (Child-Pugh score 5-9). However, use caution when administering this medicine to patients with moderate hepatic impairment because experience with its use in these patients is limited. Do not administer this medicine to patients with severe hepatic impairment (Child-Pugh score >9), as there is no experience with its use in these patients. Patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 mL/min or more). Do not administer this medicine to patients with severe renal impairment (creatinine clearance less than 30 mL/min). Older adults: No dose adjustment is required in older adults.

This medication may pose a risk of gastrointestinal bleeding for individuals who regularly consume more than three alcoholic beverages daily, and consulting with a doctor or pharmacist is essential. This medication may cause cardiovascular issues and increase the risk of serious diseases like myocardial infarction or stroke. Individuals with cardiovascular diseases or risk factors should use this medication for the shortest necessary duration and seek immediate medical attention if symptoms occur. This drug can impose a burden on the gastrointestinal tract, leading to severe gastrointestinal issues like bleeding, ulcers, or perforation; thus, caution is needed for those with a history of gastrointestinal disorders or the elderly. If symptoms such as epigastric pain, indigestion, black stools, or hematemesis occur, immediate consultation with a healthcare provider should be sought. This medication should not be administered to patients who have specific allergic reactions or suffer from asthma, uncontrolled hypertension, heart failure, severe liver or kidney diseases, or active gastric ulcers. Women who are pregnant or may become pregnant and those who are breastfeeding should not use this medication. Patients with weakened liver or kidney function, hypertension, heart failure, or asthma should take this medication cautiously and undergo regular check-ups. Various side effects may occur with this medication; common symptoms include abdominal pain, headache, hypertension, edema, dizziness, and dyspepsia. Rarely, serious allergic reactions, liver function disorders, cardiovascular issues, or skin rashes may occur, so if abnormal symptoms arise, usage should be stopped immediately, and consultation with a doctor is necessary. This medication can interact with other drugs, so especially if patients are taking anticoagulants, antihypertensive medications, diuretics, methotrexate, or oral contraceptives, they must inform healthcare providers. Dizziness or drowsiness may arise during usage, so caution is needed while driving or operating machinery. This medication may be harmful to the fetus, especially in late pregnancy, so it should not be taken during pregnancy, and women planning to become pregnant should consult a doctor beforehand. Safety in pediatric patients and adolescents under 18 years old has not been established, hence use is not recommended. Elderly patients may have diminished kidney, liver, or heart function, thus extra caution is required when taking this medication. Regular blood tests and liver/kidney function tests should be conducted during treatment to check for abnormalities. In case of overdose, symptoms such as nausea, vomiting, drowsiness, gastrointestinal bleeding, and kidney dysfunction may occur, necessitating immediate medical intervention. This medication should be stored out of the reach of children and should not be transferred to other containers for safety.

Gastrointestinal bleeding, serious cardiovascular thrombotic reactions, myocardial infarction, stroke, osteomyelitis, gastritis, upper respiratory infection, urinary tract infection, anemia, leukopenia, thrombocytopenia, hypersensitivity reactions, angioedema, anaphylaxis, shock, edema, fluid retention, increased appetite, decreased appetite, weight gain, anxiety, depression, decreased mental acuity, hallucinations, confusion, restlessness, dizziness, headache, taste disturbances, insomnia, sensory disturbances, sensory loss, drowsiness, intracranial bleeding, blurred vision, conjunctivitis, tinnitus, vertigo, palpitations, arrhythmia, atrial fibrillation, tachycardia, congestive heart failure, nonspecific ECG changes, angina, hypertension, flushing, cerebrovascular events, transient ischemic attack, hypertensive crisis, vasculitis, deep vein thrombosis, bronchospasm, cough, dyspnea, nosebleed, pulmonary embolism, abdominal pain, constipation, distension, gastritis, heartburn, acid reflux, diarrhea, dyspepsia, upper abdominal discomfort, nausea, vomiting, esophagitis, oral ulcers, abdominal distension, changes in bowel movements, dry mouth, peptic ulcer, gastrointestinal perforation, peptic ulcer disease, irritable bowel syndrome, pancreatitis, increased alanine aminotransferase, increased aspartate aminotransferase, hepatitis, liver failure, jaundice, petechiae, facial edema, itching, rash, erythema, urticaria, Stevens-Johnson syndrome, toxic epidermal necrolysis, fixed drug eruption, muscle cramps, musculoskeletal pain, musculoskeletal stiffness, proteinuria, increased serum creatinine, renal failure, renal impairment, weakness, fatigue, cold-like illness, chest pain, increased blood urea nitrogen, increased creatine phosphokinase, hyperkalemia, increased uric acid, decreased serum sodium

This medication should be stored in a tightly closed container to protect it from air and moisture, ideally at room temperature between 1°C and 30°C. Storing it this way will help maintain the drug's effectiveness for a long time.

Appearance

Biconvex film-coated tablets in blue-green apple shape

Package unit

30 tablets/PTP (10 tablets/PTPX3)